Biomarkers in Concussion

Medstar Health Research Institute100 enrolled

Overview

This will be an observational study measuring serum Neurofilament Light Chain concentrations and associated symptoms, with a control branch, and a post-concussion branch.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Concussion, Mild Concussion, Intermediate Concussion, Severe

Eligibility

Sex: ALLMin age: 14 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: Over 12 years of age Athletes participating on a sports team willing to participate; undergo blood draws either weekly or every two weeks, depending on arm of study. Exclusion criteria: Existing active neurodegenerative disorder (ie severe TBI) Active peripheral nerve disorder (ie diabetic neuropathy)

Outcomes

Primary Outcomes

Normalization of NfL levels

Time frame: 12 weeks

Secondary Outcomes

Resolution of concussion symptoms

Time frame: 12 weeks

Central Contacts

Emma Merrill

CONTACT

2028776607 emma.merrill@medstar.net

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.